Midland Wealth Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.5M Sell
10,241
-567
-5% -$132K 0.13% 38
2025
Q4
$2.24M Sell
10,808
-1,671
-13% -$330K 0.12% 37
2025
Q3
$2.31M Sell
12,479
-1,442
-10% -$247K 0.12% 37
2025
Q2
$2.13M Sell
13,921
-2,311
-14% -$355K 0.12% 42
2025
Q1
$2.69M Sell
16,232
-1,346
-8% -$211K 0.16% 33
2024
Q4
$2.54M Sell
17,578
-400
-2% -$62K 0.15% 39
2024
Q3
$2.91M Buy
17,978
+1,024
+6% +$163K 0.17% 32
2024
Q2
$2.48M Sell
16,954
-553
-3% -$82.2K 0.15% 41
2024
Q1
$2.77M Sell
17,507
-64
-0.4% -$10.2K 0.17% 33
2023
Q4
$2.75M Buy
+17,571
New +$2.69M 0.19% 29

Other funds holding JNJ

Midland Wealth Advisors's JNJ Position: Q1 2026 in Review

Midland Wealth Advisors reduced its Johnson & Johnson (JNJ) stake by 5.2% in Q1 2026, selling an estimated $132K and leaving 10,241 shares worth $2.5M. The position accounts for 0.13% of the portfolio, ranked #38.

Midland Wealth Advisors first reported a position in JNJ in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.91M in Q3 2024. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Midland Wealth Advisors held 10,241 shares of Johnson & Johnson worth $2.5M as of Q1 2026.
  • Midland Wealth Advisors sold 567 Johnson & Johnson shares in Q1 2026, an estimated $132K.
  • Johnson & Johnson made up 0.13% of Midland Wealth Advisors's portfolio in Q1 2026, its #38 holding.
  • Midland Wealth Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 10 quarters since.
  • Midland Wealth Advisors's Johnson & Johnson position peaked at $2.91M in Q3 2024.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Midland Wealth Advisors's 13F filing for Q1 2026, filed 7 May 2026.